Business Context and Reporting Period
This Form 8-K reports on the results of Progyny, Inc.'s 2024 Annual Meeting of Stockholders held on May 23, 2024. The filing details the voting outcomes for three specific proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results rather than financial performance data.
Material Changes and Voting Results
A total of 90,037,222 shares (93.68% of shares entitled to vote) were represented at the meeting. The results for the three proposals were as follows:
- Proposal 1 (Election of Directors): All four Class II director nominees were elected. However, significant dissent was recorded, with "Votes Against" ranging from approximately 16.9 million to 21.7 million shares per nominee.
- Proposal 2 (Ratification of Auditors): Stockholders ratified the selection of Ernst & Young LLP. The proposal passed with 89,543,602 votes for and 330,834 votes against.
- Proposal 3 (Executive Compensation): Stockholders approved the advisory compensation of named executive officers. The proposal passed with 82,109,794 votes for and 1,914,294 votes against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies. The document serves solely to disclose the final voting tallies from the Annual Meeting.
Important Facts for Investors to Verify
- Verify the reasons behind the high volume of "Votes Against" for the director nominees, which exceeded 16 million shares for each candidate.
- Confirm the total number of shares outstanding to contextualize the 93.68% participation rate.
- Review the Company's proxy statement filed on April 12, 2024, for detailed descriptions of the proposals and management's response to the voting results.